Neoadjuvant Durvalumab plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable EGFR-mutated NSCLC (AEGEAN)

He, J; Gao, S; Reck, M; Harpole, D; Mitsudomi, T; Taube, JM; Lee, KY; Horio, Y; Runglodvatana, Y; Aperghis, M; Doherty, GJ; Laud, PJ; Fouad, TM; Heymach, JV

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (11): S72

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索